Circulation Research, Vol 63, 380-385, Copyright © 1988 by American Heart Association

ARTICLES

Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency

ED Pagani, AA Alousi, AM Grant, TM Older, SW Dziuban Jr and PD Allen
Molecular Cardiology Unit, Sterling-Winthrop Research Institute, Rensselaer, New York 12144.

Force development and shortening by cardiac muscle occur as a result of the interaction between actin and myosin within the myofibrillar lattice. This interaction is dependent upon intracellular ionized calcium and is controlled by the troponin-tropomyosin regulatory proteins situated along the actin filament. In this study, we compared the myofibrillar content and myofibrillar Mg-ATPase activity of normal human ventricular muscle with that of ventricular muscle from patients in end-stage failure caused by coronary artery disease or cardiomyopathy and ventricular muscle from patients with heart failure due to mitral valve insufficiency. The results show that the amount of myofibrillar protein (mg/g wet wt ventricle) in hearts in end-stage failure (coronary artery disease and cardiomyopathy) is significantly lower compared with normal hearts and hearts in failure due to mitral valve insufficiency. However, the Mg-ATPase activity of myofibrils from hearts in both end-stage failure and failure due to mitral valve insufficiency is significantly lower compared with myofibrils from normal hearts. The data suggest that the reduction in the amount of myofibrillar protein in ventricular tissue is a pivotal event that may be responsible for the progression of heart disease to the point of end- stage failure.

This article has been cited by other articles:

				N. S. Dhalla, H. K. Saini-Chohan, D. Rodriguez-Leyva, V. Elimban, M. R. Dent, and P. S. Tappia Subcellular remodelling may induce cardiac dysfunction in congestive heart failure Cardiovasc Res, February 15, 2009; 81(3): 429 - 438. [Abstract] [Full Text] [PDF]

				N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden Sarcomeric dysfunction in heart failure Cardiovasc Res, March 1, 2008; 77(4): 649 - 658. [Abstract] [Full Text] [PDF]

				M. C. G. Daniels, T. Naya, V. L. M. Rundell, and P. P. de Tombe Development of contractile dysfunction in rat heart failure: hierarchy of cellular events Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R284 - R292. [Abstract] [Full Text] [PDF]

				J. Layland, R. J. Solaro, and A. M. Shah Regulation of cardiac contractile function by troponin I phosphorylation Cardiovasc Res, April 1, 2005; 66(1): 12 - 21. [Abstract] [Full Text] [PDF]

				L. Elsherif, Y. Jiang, J. T. Saari, and Y. J. Kang Dietary Copper Restriction-Induced Changes in Myocardial Gene Expression and the Effect of Copper Repletion Experimental Biology and Medicine, July 1, 2004; 229(7): 616 - 622. [Abstract] [Full Text] [PDF]

				S. B. Marston and C. S. Redwood Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications Circ. Res., December 12, 2003; 93(12): 1170 - 1178. [Abstract] [Full Text] [PDF]

				X. He, Y. Liu, V. Sharma, R. T. Dirksen, R. Waugh, S.-S. Sheu, and W. Min ASK1 Associates with Troponin T and Induces Troponin T Phosphorylation and Contractile Dysfunction in Cardiomyocytes Am. J. Pathol., July 1, 2003; 163(1): 243 - 251. [Abstract] [Full Text] [PDF]

				A. V. Gomes, G. Guzman, J. Zhao, and J. D. Potter Cardiac Troponin T Isoforms Affect the Ca2+ Sensitivity and Inhibition of Force Development. INSIGHTS INTO THE ROLE OF TROPONIN T ISOFORMS IN THE HEART J. Biol. Chem., September 13, 2002; 277(38): 35341 - 35349. [Abstract] [Full Text] [PDF]

				J. N Peterson, R. Nassar, P. A W Anderson, and N. R Alpert Altered cross-bridge characteristics following haemodynamic overload in rabbit hearts expressing V3 myosin J. Physiol., October 15, 2001; 536(2): 569 - 582. [Abstract] [Full Text] [PDF]

				M. O. Boluyt, S. T. Devor, J. A. Opiteck, and T. P. White Age Effects on the Adaptive Response of the Female Rat Heart Following Aortic Constriction J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2000; 55(6): 307B - 314. [Abstract] [Full Text]

				T. Kaneko, H. Tanaka, M. Oyamada, S. Kawata, and T. Takamatsu Three Distinct Types of Ca2+ Waves in Langendorff-Perfused Rat Heart Revealed by Real-Time Confocal Microscopy Circ. Res., May 26, 2000; 86(10): 1093 - 1099. [Abstract] [Full Text] [PDF]

				I. F Purcell, W. Bing, and S. B Marston Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts Cardiovasc Res, September 1, 1999; 43(4): 884 - 891. [Abstract] [Full Text] [PDF]

				J. Wattanapermpool and P. J. Reiser Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H467 - H473. [Abstract] [Full Text] [PDF]

				J. K. Gwathmey, C. S. Kim, R. J. Hajjar, F. Khan, T. G. DiSalvo, A. Matsumori, and M. R. Bristow Cellular and molecular remodeling in a heart failure model treated with the beta -blocker carteolol Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1678 - H1690. [Abstract] [Full Text] [PDF]

				T. Kameyama, Z. Chen, S. P. Bell, P. VanBuren, D. Maughan, and M. M. LeWinter Mechanoenergetic Alterations During the Transition From Cardiac Hypertrophy to Failure in Dahl Salt-Sensitive Rats Circulation, December 22, 1998; 98(25): 2919 - 2929. [Abstract] [Full Text] [PDF]

				T. Ruf, H. Schulte-Baukloh, J. Ludemann, H. Posival, F. Beyersdorf, H. Just, and C. Holubarsch Alterations of cross-bridge kinetics in human atrial and ventricular myocardium Cardiovasc Res, December 1, 1998; 40(3): 580 - 590. [Abstract] [Full Text] [PDF]

				C Mittmann, T Eschenhagen, and H Scholz Cellular and molecular aspects of contractile dysfunction in heart failure Cardiovasc Res, August 1, 1998; 39(2): 267 - 275. [Full Text] [PDF]

				P. P de Tombe Altered contractile function in heart failure Cardiovasc Res, February 1, 1998; 37(2): 367 - 380. [Abstract] [Full Text] [PDF]

				G. S. Bodor, A. E. Oakeley, P. D. Allen, D. L. Crimmins, J. H. Ladenson, and P. A. W. Anderson Troponin I Phosphorylation in the Normal and Failing Adult Human Heart Circulation, September 2, 1997; 96(5): 1495 - 1500. [Abstract] [Full Text]

				A. Malhotra and V. Sanghi Regulation of contractile proteins in diabetic heart Cardiovasc Res, April 1, 1997; 34(1): 34 - 40. [Abstract] [Full Text] [PDF]

				T.-T. T. Nguyen, E. Hayes, L. A. Mulieri, B. J. Leavitt, H. E.D.J. ter Keurs, N. R. Alpert, and D. M. Warshaw Maximal Actomyosin ATPase Activity and In Vitro Myosin Motility Are Unaltered in Human Mitral Regurgitation Heart Failure Circ. Res., August 1, 1996; 79(2): 222 - 226. [Abstract] [Full Text]

				P. VanBuren, D. E. Harris, N. R. Alpert, and D. M. Warshaw Cardiac V1 And V3 Myosins Differ in Their Hydrolytic and Mechanical Activities In Vitro Circ. Res., August 1, 1995; 77(2): 439 - 444. [Abstract] [Full Text]

				P. A. W. Anderson, A. Greig, T. M. Mark, N. N. Malouf, A. E. Oakeley, R. M. Ungerleider, P. D. Allen, and B. K. Kay Molecular Basis of Human Cardiac Troponin T Isoforms Expressed in the Developing, Adult, and Failing Heart Circ. Res., April 1, 1995; 76(4): 681 - 686. [Abstract] [Full Text]

				L.A. Mulieri, W. Barnes, B.J. Leavitt, F.P. Ittleman, M.M. LeWinter, N.R. Alpert, and D.W. Maughan Alterations of Myocardial Dynamic Stiffness Implicating Abnormal Crossbridge Function in Human Mitral Regurgitation Heart Failure Circ. Res., January 11, 2002; 90(1): 66 - 72. [Abstract] [Full Text] [PDF]